We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$429M
AUM Growth
+$15.6M
Cap. Flow
-$14.6M
Cap. Flow %
-3.41%
Top 10 Hldgs %
33.76%
Holding
359
New
78
Increased
48
Reduced
96
Closed
13

Top Buys

Rank Stock Value
1
TPL icon
Texas Pacific Land
TPL
+$2.52M
2
EWBC icon
East-West Bancorp
EWBC
+$1.14M
3
MSFT icon
Microsoft
MSFT
+$1.02M
4
AAPL icon
Apple
AAPL
+$888K
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$757K

Sector Composition

Rank Sector Weight
1 Technology 27.2%
2 Healthcare 17.72%
3 Consumer Discretionary 10.22%
4 Financials 8.22%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
301
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$12K ﹤0.01%
1,200
XPO icon
302
XPO
XPO
$23.8B
$11.7K ﹤0.01%
350
-239
-41% -$8.05K
ROK icon
303
Rockwell Automation
ROK
$49.6B
$11.6K ﹤0.01%
45
EMBC icon
304
Embecta
EMBC
$276M
$10.8K ﹤0.01%
429
-1,017
-70% -$31.1K
WK icon
305
Workiva
WK
$3.76B
$10.7K ﹤0.01%
+127
New +$9.84K
IBM icon
306
IBM
IBM
$225B
$10.6K ﹤0.01%
75
BOOT icon
307
Boot Barn
BOOT
$5.02B
$10.1K ﹤0.01%
+162
New +$9.71K
LIN icon
308
Linde
LIN
$226B
$10.1K ﹤0.01%
31
FIVN icon
309
FIVE9
FIVN
$2.44B
$9.57K ﹤0.01%
+141
New +$8.85K
SMG icon
310
ScottsMiracle-Gro
SMG
$3.61B
$9.47K ﹤0.01%
195
SWAV
311
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$9.25K ﹤0.01%
+45
New +$11.4K
AMP icon
312
Ameriprise Financial
AMP
$49.7B
$9.03K ﹤0.01%
+29
New +$8.85K
CXM icon
313
Sprinklr
CXM
$1.61B
$8.78K ﹤0.01%
+1,074
New +$9.3K
PH icon
314
Parker-Hannifin
PH
$134B
$8.73K ﹤0.01%
+30
New +$8.59K
VHT icon
315
Vanguard Health Care ETF
VHT
$19B
$8.68K ﹤0.01%
35
SHW icon
316
Sherwin-Williams
SHW
$88.5B
$8.54K ﹤0.01%
+36
New +$8.32K
SLB icon
317
SLB Ltd
SLB
$79.7B
$8.45K ﹤0.01%
+158
New +$7.87K
LYB icon
318
LyondellBasell Industries
LYB
$20.7B
$8.3K ﹤0.01%
100
XBI icon
319
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$8.3K ﹤0.01%
100
VICR icon
320
Vicor
VICR
$9.72B
$8.28K ﹤0.01%
+154
New +$8.1K
ADPT icon
321
Adaptive Biotechnologies
ADPT
$4.04B
$7.64K ﹤0.01%
1,000
DEO icon
322
Diageo
DEO
$52.8B
$6.95K ﹤0.01%
39
CHTR icon
323
Charter Communications
CHTR
$18.8B
$6.78K ﹤0.01%
20
QDEL icon
324
QuidelOrtho
QDEL
$959M
$6.42K ﹤0.01%
75
-112
-60% -$9.49K
PLTR icon
325
Palantir
PLTR
$420B
$6.42K ﹤0.01%
1,000

Similar funds

Arcadia Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Arcadia Investment Management held 359 positions worth $429M, up 3.8% from $413M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Arcadia Investment Management withdrew a net $14.6M in Q4 2022, closing 13 positions and reducing 96 holdings. Its most notable exit was iShares iBonds Dec 2022 Term Corporate ETF, an estimated $596K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Arcadia Investment Management opened a new position in Freeport-McMoran worth $380K.

  • Arcadia Investment Management's largest Q4 2022 buy was Freeport-McMoran: 10,000 shares worth $380K.
  • Arcadia Investment Management added most to Texas Pacific Land in Q4 2022, an estimated $2.52M increase.
  • Arcadia Investment Management's biggest Q4 2022 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $4.92M.
  • Arcadia Investment Management fully exited iShares iBonds Dec 2022 Term Corporate ETF in Q4 2022, selling an estimated $596K.
  • Arcadia Investment Management's ten largest holdings make up 34% of its $429M portfolio in Q4 2022.
  • Arcadia Investment Management opened 78 new positions and closed 13 in Q4 2022.
  • Arcadia Investment Management's portfolio value rose 3.8% quarter-over-quarter to $429M.

Based on Arcadia Investment Management's 13F filing for Q4 2022, filed 8 Feb 2023.